miR-142-3p not only restraints the generation and reduces the immunosuppressive activity of M-MDSCs, but also restores CD8+ T cells proliferation through modulating STAT3 and C/EBPβ signal pathways during tumor-induced myelopoiesis (75). The gene discussed is CD8A; the disease is neoplasm.